Open original FDA record ↗Recall record
- FDA identifier
- Z-0921-2021
- Company in FDA record
- OMNIlife science Inc.
- FDA record creation date
- Jan 26, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Acetabular Liners have a higher than acceptable oxidation limit, potential for patients to experience a higher wear rate for acetabular liners and require a revision surgery
Source facts
- Action
- Omni Life Initial communication was sent by email via a quarantine form on 12/09/2020. On 12/22/20 a notification packet detailing parameters of recall sent via email and overnight mail. Acknowledgement of receipt is requested. Actions to be taken by the Customer/User " Immediately quarantine lots 28413, 28624 and 28572 " Return Product to OMNI at 480 Paramount Drive, Raynham MA 02767 " This advisory notice only includes the lots identified above. It does not affect other lots. You must acknowledge this notice by returning the attached Acknowledgement and Receipt Form by FAX to 508-819-3390 or my email to Omni-cs@coringroup.com.
- Initiated
- 2020-12-21
- Root cause
- Under Investigation by firm
- Terminated
- 2021-06-10
- Distribution
- AL, ID, MD, NY, OK
- Recall number
- Z-0921-2021
- Recall status
- Terminated
- CDRH record ID
- 185145
- FDA record created
- 2021-01-26
- Recall event number
- 87062